Skip to main content
. 2022 Jan 4;98(1):e40–e50. doi: 10.1212/WNL.0000000000012952

Table 2.

Number of Participants With Any Serious Adverse Event and Treatment-Emergent Adverse Events That Occurred in >2 Participants by MedDRA Preferred Term

graphic file with name NEUROLOGY2021172193t2.jpg